Walters v. AngioDynamics, Inc.

UNITED STATES DISTRICT COURT

DISTRICT OF MASSACHUSETTS

*

JIMMY WALTERS, *

*

Plaintiff, *

*

v. *

* Civil Action No. 21-cv-11225-ADB

ANGIODYNAMICS, INC. and NAVILYST *

MEDICAL, INC., *

*

Defendants. *

*

MEMORANDUM AND ORDER

BURROUGHS, D.J.

Plaintiff Jimmy Walters alleges that he was injured by a defective medical device made

by Defendants AngioDynamics, Inc. (“AngioDynamics”) and Navilyst Medical, Inc. (“Navilyst,”

and, together with AngioDynamics, “Defendants”). [ECF No. 1-1]. Currently before the Court

are Mr. Walters’ motion for remand, [ECF No. 15], and Defendants’ motion to dismiss for lack

of personal jurisdiction, [ECF No. 8]. For the reasons set forth below, Mr. Walters’ motion is

DENIED, and Defendants’ motion is GRANTED. Mr. Walters’ complaint is DISMISSED

without prejudice.

I. BACKGROUND

A. Factual Background

The following facts are taken primarily from the complaint, [ECF No. 1-1], the factual

allegations of which are assumed to be true when considering a motion to dismiss. Ruivo v.

Wells Fargo Bank, N.A., 766 F.3d 87, 90 (1st Cir. 2014).

Mr. Walters is a Texas resident. [ECF No. 1-1 ¶ 2]. AngioDynamics and Navilyst are

both Delaware corporations. [Id. ¶¶ 3–4].

In or around 2007, Rita Medical Systems, Inc. (“Rita”) received clearance from the U.S.

Food and Drug Administration to market and sell a vascular access device called the Vortex CT

Port-Access System. [ECF No. 1-1 ¶ 15]. Around the same time, AngioDynamics acquired

Rita’s assets and liabilities and rebranded the device as the SmartPort CT (the “Device”). [Id.

¶ 16]. The Device is designed to deliver medication, intravenous fluids, parenteral nutrition

solutions, and blood products directly into the bloodstream. [Id. ¶ 19]. The Device consists of

two parts: an injection port and a polyurethane catheter. [Id. ¶ 21]. Because of an alleged design

and manufacturing defect, the catheter sometimes fractures, which can lead to devastating

results. [Id. ¶¶ 23–30, 34]. Before Mr. Walters was implanted with the Device, Defendants were

aware that catheters were fracturing and pieces were migrating through patients’ bodies, with

catastrophic consequences. [Id. ¶¶ 38–42].

On March 1, 2019, Mr. Walters was implanted with the Device at a hospital in Texas.

[ECF No. 1-1 ¶ 47]. On July 1, 2019, the Device, and fractured fragments from its catheter, were

surgically removed from Mr. Walters at the same hospital. [Id. ¶ 48]. As a result of this ordeal,

Mr. Walters experienced significant mental and physical pain and suffering, sustained physical

injuries and permanent physical deformities, underwent (and will undergo additional) corrective

surgery, and suffered financial and economic losses (including medical expenses and lost

wages). [Id. ¶ 55].

B. Procedural Background

Mr. Walters filed this suit in Middlesex County Superior Court on June 14, 2021. [ECF

No. 1-1]. On July 29, 2021, Defendants removed the case. [ECF No. 1]. On August 5, 2021,

Defendants moved to dismiss for lack of personal jurisdiction. [ECF No. 8]. Mr. Walters

opposed on September 3, 2021, [ECF No. 22], and Defendants replied on September 22, 2021,

[ECF No. 26]. Additionally, Mr. Walters filed a motion for remand on August 30, 2021, [ECF

No. 15], which Defendants opposed on September 13, 2021, [ECF No. 25].

II. MR. WALTERS’ MOTION FOR REMAND

Defendants removed this case based on diversity jurisdiction. See [ECF No. 1 ¶ 4].

“Federal diversity jurisdiction is available in cases arising between citizens of different states in

which the amount in controversy exceeds $75,000.” Rizzi v. 178 Lowell St. Operating Co., 180

F. Supp. 3d 66, 67 (D. Mass. 2016) (citing 28 U.S.C. § 1332(a)). Mr. Walters acknowledges that

the diversity and amount-in-controversy requirements are satisfied here but maintains that

because Defendants are Massachusetts citizens, the “forum defendant rule” precludes removal.

[ECF No. 16 at 3 (emphasis omitted)]. Defendants counter that the forum defendant rule has no

bearing here because they are not Massachusetts citizens.1 [ECF No. 25 at 11–19].

Removal premised on diversity jurisdiction is improper “if any of the parties in interest

properly joined and served as defendants is a citizen of the State in which such action is

brought.” 28 U.S.C. § 1441(b)(2). “This is known as the ‘forum defendant rule.’” DaSilva v.

Baader Ger., 514 F. Supp. 3d 393, 397 (D. Mass. 2021) (quoting Rizzi, 180 F. Supp. 3d at 68).

“A corporation’s citizenship, for diversity jurisdiction purposes, is both the state where it is

1 Defendants also argue that Mr. Walters’ motion should be denied as untimely because he filed

it after 6:00 p.m. on the day it was due. [ECF No. 25 at 10–11]; see L.R. 5.4(d) (“Although the

ECF system is generally available 24 hours a day for electronic filing, that availability will not

alter filing deadlines, whether set by rule, court order, or stipulation. All electronic transmissions

of documents must be completed prior to 6:00 p.m. to be considered timely filed that day.”). The

Court will exercise its discretion to excuse Mr. Walters’ failure to strictly comply with Local

Rule 5.4(d) and consider the merits of his motion. See Soo v. Bone Biologics Corp., No.

19-cv-11520, 2021 WL 1391458, at *4 (D. Mass. Apr. 13, 2021).

incorporated and the state ‘where it has its principal place of business.’” Celli v. Greenwich Ins.

Co., 478 F. Supp. 3d 93, 95–96 (D. Mass. 2020) (quoting 28 U.S.C. § 1332(c)(1)).

It is undisputed that Defendants are incorporated in Delaware. See [ECF No. 1-1 ¶¶ 3–4;

ECF No. 1-2 ¶¶ 3, 7]. Accordingly, the forum defendant rule would be applicable only if either

AngioDynamics or Navilyst has its principal place of business in Massachusetts. For the reasons

that follow, the Court finds that both AngioDynamics and Navilyst have their principal places of

business in New York.

Several years ago, the Supreme Court established beyond any doubt that federal

courts must employ the “nerve center” test to determine the location of a

corporation’s principal place of business. The test is straightforward. A

corporation’s “nerve center” (i.e., its principal place of business) is the particular

location from which its “officers direct, control, and coordinate the corporation’s

activities.” Generally speaking, this will “be the place where the corporation

maintains its headquarters—provided that the headquarters is the actual center of

direction, control, and coordination . . . and not simply an office where the

corporation holds its board meetings (for example, attended by directors and

officers who have traveled there for the occasion).”

Harrison v. Granite Bay Care, Inc., 811 F.3d 36, 40 (1st Cir. 2016) (citations omitted) (quoting

Hertz Corp. v. Friend, 559 U.S. 77, 80–81, 92–93 (2010)). “At its heart, the nerve center test is

an inquiry to find the one location from which a corporation is ultimately controlled.” Id. at 41.

Based on the nerve center test, it is clear that Defendants’ principal places of business are

in New York. As noted in an affidavit filed by Stephen A. Trowbridge, AngioDynamics’

Executive Vice President and CFO: (1) Navilyst is a wholly-owned subsidiary of

AngioDynamics, [ECF No. 1-2 ¶ 6]; (2) Navilyst’s U.S. operations are “entirely carried out and

controlled by AngioDynamics,” [id. ¶ 9]; (3) the people who work for Navilyst are

AngioDynamics’ employees, [id. ¶ 10]; (4) AngioDynamics’ chief executives (including its

CEO, CFO, and General Counsel) and its accounting, legal, and human resources departments

are based in New York, [id. ¶ 8]; and (5) “[a]ll significant corporate decisions,” for both

AngioDynamics and Navilyst, are made, or reviewed and approved, by executives based in New

York, [id. ¶ 11].2 In light of this uncontroverted evidence, the Court finds that Defendants are

“ultimately controlled” from New York. See Harrison, 811 F.3d at 41.

Mr. Walters advances evidence purportedly demonstrating that Defendants have their

principal places of business in Massachusetts, [ECF No. 16 at 4–8], but the Court has already

rejected nearly-identical evidence in two nearly-identical cases, Pettit v. AngioDynamics, Inc.,

No. 21-cv-10568, 2021 WL 4441261, at *3–4 (D. Mass. Sept. 28, 2021); Harness v.

AngioDynamics, Inc., No. 21-cv-10233, 2021 WL 4441260, at *3–4 (D. Mass. Sept. 28, 2021),3

and is no more persuaded this time around. At bottom, while Mr. Walters claims that

Defendants’ principal places of business are in Massachusetts, see, e.g., [ECF No. 16 at 2, 7], the

evidence belies his position. Because Defendants’ principal places of business are not in

Massachusetts, the forum defendant rule does not preclude removal. Mr. Walters’ motion for

remand, [ECF No. 15], is therefore DENIED.

III. DEFENDANTS’ MOTION TO DISMISS FOR LACK OF PERSONAL

JURISDICTION

The parties dispute whether Defendants are subject to the Court’s personal jurisdiction.

See [ECF No. 9; ECF No. 22]. For the reasons set forth below, the Court finds that they are not.

2 In his opposition to Defendants’ motion to dismiss, Mr. Walters argues that the Court must

disregard Mr. Trowbridge’s affidavit because it is not uncontroverted. [ECF No. 22 at 18–19].

This argument fails, however, because the evidence that Mr. Walters points to does not, in fact,

contradict Mr. Trowbridge’s sworn statements. Accordingly, the Court may (and will) consider

Mr. Trowbridge’s affidavit.

3 Judge Casper has also rejected nearly-identical arguments and evidence in a nearly-identical

case. Kingston v. AngioDynamics, Inc., No. 21-cv-10234, 2021 WL 3022320, at *4 (D. Mass.

July 16, 2021); see Electronic Order, Kingston v. AngioDynamics, Inc., No. 21-cv-10234 (D.

Mass. Oct. 4, 2021), ECF No. 41 (denying reconsideration of order dismissing case).

A. Legal Standard

Mr. Walters bears the burden of establishing that jurisdiction exists over Defendants. A

Corp. v. All Am. Plumbing, Inc., 812 F.3d 54, 58 (1st Cir. 2016) (citing Phillips v. Prairie Eye

Ctr., 530 F.3d 22, 26 (1st Cir. 2008)). “When a district court rules on a motion to dismiss for

lack of personal jurisdiction without holding an evidentiary hearing . . . the ‘prima facie’

standard governs its determination.” United States v. Swiss Am. Bank, Ltd., 274 F.3d 610, 618

(1st Cir. 2001). Under the prima facie standard, the plaintiff must proffer “evidence which, if

credited, is sufficient to support findings of all facts essential to personal jurisdiction.” A Corp.,

812 F.3d at 58 (quoting Prairie Eye Ctr., 530 F.3d at 26). “[P]laintiffs may not rely on

unsupported allegations in their pleadings,” and are instead “obliged to adduce evidence of

specific facts” supporting jurisdiction. Platten v. HG Berm. Exempted Ltd., 437 F.3d 118, 134

(1st Cir. 2006) (alteration in original) (first quoting Boit v. Gar-Tec Prods., Inc., 967 F.2d 671,

675 (1st Cir. 1992); then quoting Foster-Miller, Inc. v. Babcock & Wilcox Can., 46 F.3d 138,

145 (1st Cir. 1995)). The Court takes as true whatever properly documented facts a plaintiff

proffers, construes those facts in the light most favorable to the plaintiff, and considers facts put

forward by the defendant only to the extent that they are uncontradicted. See Prairie Eye Ctr.,

530 F.3d at 26; Platten, 437 F.3d at 134.

“In determining whether a non-resident defendant is subject to its jurisdiction, a federal

court exercising diversity jurisdiction ‘is the functional equivalent of a state court sitting in the

forum state.’” Daynard v. Ness, Motley, Loadholt, Richardson & Poole, P.A., 290 F.3d 42, 51

(1st Cir. 2002) (quoting Sawtelle v. Farrell, 70 F.3d 1381, 1387 (1st Cir. 1995)). “Accordingly,

this Court may only exercise personal jurisdiction within the limits set by Massachusetts’

long-arm statute and the due process clause of the Constitution.” Kingston v. AngioDynamics,

Inc., No. 21-cv-10234, 2021 WL 3022320, at *5 (D. Mass. July 16, 2021) (citing Lyle Richards

Int’l, Ltd. v. Ashworth, Inc., 132 F.3d 111, 112 (1st Cir. 1997)).

B. Jurisdiction Under the Massachusetts Long-Arm Statute

“Because the [Massachusetts] long-arm statute imposes specific constraints on the

exercise of personal jurisdiction that are not coextensive with the parameters of due process . . . a

determination under the long-arm statute is to precede consideration of the constitutional

question.” SCVNGR, Inc. v. Punchh, Inc., 85 N.E.3d 50, 52 (Mass. 2017). Section 3 of the

Massachusetts long-arm statute allows for the exercise of “personal jurisdiction over a person,

who acts directly or by an agent, as to a cause of action in law or equity arising from” various

activities within or outside of the Commonwealth. Mass. Gen. Laws ch. 223A, § 3.

Mr. Walters relies on § 3(a) of the Massachusetts long-arm statute, see [ECF No. 22 at

12–13], which provides for the exercise of personal jurisdiction based on a defendant’s

“transacting any business in this commonwealth.” Mass. Gen. Laws. ch. 223A, § 3(a). Section

3(a)’s “reference to ‘transacting any business’ does not require that the defendant have engaged

in commercial activity. That language is general and applies to any purposeful acts by an

individual, whether personal, private, or commercial.” Ealing Corp. v. Harrods Ltd., 790 F.2d

978, 982 (1st Cir. 1986) (quoting Ross v. Ross, 358 N.E.2d 437, 439 (Mass. 1976)). “[T]he

defendant’s involvement need not be major, as ‘just a few acts on [his] part can often suffice to

satisfy [subsection (a)]’s threshold for transacting business.’” Scuderi Grp., LLC v. LGD Tech.,

LLC, 575 F. Supp. 2d 312, 319 (D. Mass. 2008) (second and third alterations in original)

(quoting Workgroup Tech. Corp. v. MGM Grand Hotel, LLC, 246 F. Supp. 2d 102, 110 (D.

Mass. 2003)). “The ‘arising from’ clause in [the Massachusetts long-arm statute] is to be

generously construed in favor of asserting personal jurisdiction, by applying a ‘but for’ causation

test.” Workgroup Tech. Corp., 246 F. Supp. 2d at 112. “[A] claim arises from a defendant’s

transaction of business in the forum State if the claim was made possible by, or lies in the wake

of, the transaction of business in the forum State.” Access Now, Inc. v. Otter Prods., LLC, 280

F. Supp. 3d 287, 291 (D. Mass. 2017) (alteration in original) (quoting Tatro v. Manor Care, Inc.,

625 N.E.2d 549, 553 (Mass. 1994)). The arising from inquiry asks whether “the defendant’s

contacts with the Commonwealth constitute the first step in a train of events that result[ed] in the

. . . injury.” Id. (alteration in original) (internal quotation marks omitted) (quoting Lyle Richards

Int’l, Ltd., 132 F.3d at 114).

Defendants transact business in Massachusetts. They have an office in Marlborough,

Massachusetts and appear to have a number of employees who work here. See [ECF No. 22-4 at

89 (listing address in Marlborough); ECF No. 22-10 (LinkedIn profiles indicating that certain

employees work in Massachusetts)]. Mr. Walters maintains that his claims arise from

Defendants’ business activities in Massachusetts because Defendants’ marketing, scientific and

clinical affairs, and regulatory activities all take place in Massachusetts and that but for those

activities, “the [Device] would never have reached [him], let alone precipitated his injuries.”

[ECF No. 22 at 17]. Mr. Walters cannot, however, rely on self-serving, conclusory statements to

establish jurisdiction. See Chen v. U.S. Sports Acad., Inc., 956 F.3d 45, 54 (1st Cir. 2020).

Rather, he must adduce specific evidence suggesting that Defendants’ business activities in

Massachusetts were the first step in a chain of events leading to his injuries. He has failed to do

so here.

With respect to marketing activities, Mr. Walters contends that “Defendants’ marketing

and sales strategies and practices for the [Device] . . . are conceived and directed in

Massachusetts.” [ECF No. 22 at 14]. But the evidence that he relies on—an undated patient

education pamphlet listing a Massachusetts address, [ECF No. 22-4], and the fact that certain of

Defendants’ marketing personnel have LinkedIn profiles indicating that they work in

Massachusetts, [ECF No. 22-10]—does not support his proposition. Notably, it fails to

demonstrate that Defendants conducted marketing activities related to the Device in

Massachusetts.

Mr. Walters’ next argument fares no better. He contends that Defendants’ “in-forum

management of scientific and medical affairs” gives rise to jurisdiction. [ECF No. 22 at 15].

The evidence that he relies on—the fact that Defendants’ scientific and clinical personnel have

LinkedIn profiles suggesting that they work in Massachusetts, [ECF No. 22-10 at 4–5]—does not

support his contention because it fails to show that Defendants conducted scientific and clinical

activities related to the Device in Massachusetts.

Mr. Walters encounters the same basic problem with his regulatory activities argument.

He asserts that Defendants’ “Massachusetts-based regulatory activities” subject them to personal

jurisdiction here. [ECF No. 22 at 16]. Once again, the evidence that Mr. Walters leans on—an

SEC filing, [ECF No. 22-8], documents indicating that Defendants’ Senior Vice President of

Quality and Regulatory Affairs lives in Massachusetts, [ECF No. 22-3 at 4–5], and regulatory

filings listing a Massachusetts address, [ECF No. 22-5 at 3; ECF No. 22-2 at 2–3]—does not

support his position because it fails to show that Defendants’ regulatory activities related to the

Device took place in Massachusetts.

Viewed favorably, Mr. Walters’ evidence demonstrates that Defendants have a presence

in Massachusetts and conduct some business here, including marketing, research and

development, and regulatory activities. Importantly, however, none of this evidence

demonstrates that Defendants conduct business activities related to the Device in Massachusetts.

At bottom, Mr. Walters relies on his attorneys’ arguments and unsworn representations, e.g.,

[ECF No. 22 at 11 (asserting, without citation, that Defendants “conduct business activities in

Massachusetts related to the [Device], including research, development, design, testing, post-

market surveillance, marketing, and regulatory compliance activities”)], which are insufficient to

establish jurisdiction, see Chen, 956 F.3d at 56. Notably, Mr. Trowbridge’s affidavit establishes

that all significant corporate decisions are made in New York and that all U.S. products

(including the Device) are manufactured in New York. [ECF No. 1-2 ¶¶ 11–12]. Against this

backdrop, Mr. Walters has failed to show the required link between his claims and Defendants’

Massachusetts contacts. Accordingly, the Court does not have jurisdiction over Defendants

pursuant to the Massachusetts long-arm statute.

C. Jurisdiction Under the U.S. Constitution

Although the Court could stop the analysis here, it will briefly consider jurisdiction under

the U.S. Constitution in the interests of a comprehensive record.

Courts may exercise two types of personal jurisdiction under the Due Process Clause of

the Fourteenth Amendment: general and specific. The Court discusses each in turn.

1. General Jurisdiction

“[G]eneral jurisdiction requires affiliations ‘so “continuous and systematic” as to render

[a person] essentially at home in the forum State.’” Daimler AG v. Bauman, 571 U.S. 117, 133

n.11 (2014) (quoting Goodyear Dunlop Tires Operations, S.A. v. Brown, 564 U.S. 915, 919

(2011)). Although the “paradigmatic examples of locales in which a defendant corporation is

considered at home are its state of incorporation and the state that houses its principal place of

business,” in some cases “a defendant corporation’s general business operations in a state in

which it is neither incorporated nor headquartered ‘may be so substantial and of such a nature as

to render the corporation at home in that State.’” Chen, 956 F.3d at 57 (quoting Daimler, 571

U.S. at 139 n.19).

AngioDynamics and Navilyst are both incorporated in Delaware, and the Court has

already found that they have their principal places of business in New York. Accordingly, the

Court can exercise general personal jurisdiction over them only if their “general business

operations” here are “so substantial and of such a nature as to render [them] at home” in

Massachusetts. Chen, 956 F.3d at 57 (quoting Daimler, 571 U.S. at 139 n.19). They are not.

See [ECF No. 1-2 ¶ 11 (“All significant corporate decisions for AngioDynamics and Navilyst are

made by, or subject to review and approval by, executives based out of AngioDynamics’ New

York offices.”)]; cf. Perkins v. Benguet Consol. Mining Co., 342 U.S. 437, 447–48 (1952)

(finding company subject to general jurisdiction in Ohio where company had ceased Philippines

operations during World War II and company president instead conducted business from an

office in Ohio).4

2. Specific Jurisdiction

“Specific jurisdiction exists when there is a demonstrable nexus between a plaintiff’s

claims and a defendant’s forum-based activities.” Swiss Am. Bank, Ltd., 274 F.3d at 618

(quoting Mass. Sch. of L. at Andover, Inc. v. Am. Bar Ass’n, 142 F.3d 26, 34 (1st Cir. 1998)).

For the Court to exercise specific personal jurisdiction over Defendants consistent with the Due

Process Clause, each of three conditions must be satisfied:

First, the claim underlying the litigation must directly arise out of, or relate to, the

[Defendants’] forum-state activities. Second, the [Defendants’] in-state contacts

must represent a purposeful availment of the privilege of conducting activities in

the forum state, thereby invoking the benefits and protections of that state’s laws

4 The Supreme Court has described Perkins as the “textbook case of general jurisdiction.”

Daimler, 571 U.S. at 129.

and making the [Defendants’] involuntary presence before the state’s courts

foreseeable. Third, the exercise of jurisdiction must . . . be reasonable.

Daynard, 290 F.3d at 60 (quoting Foster-Miller, Inc., 46 F.3d at 144). The inquiry “is ‘not

susceptible [to] mechanical application,’” PREP Tours, Inc. v. Am. Youth Soccer Org., 913 F.3d

11, 17 (1st Cir. 2019) (quoting Kulko v. Super. Ct. of Cal., 436 U.S. 84, 92 (1978)), rather,

“[e]ach case requires an individualized weighing of the material facts,” United Elec., Radio &

Mach. Workers v. 163 Pleasant St. Corp., 960 F.2d 1080, 1088 (1st Cir. 1992) (citing Burger

King Corp. v. Rudzewicz, 471 U.S. 462, 485–86 (1985)).

Mr. Walters’ claims do not arise out of, or relate to, Defendants’ Massachusetts contacts.

As noted above in connection with the Massachusetts long-arm statute, Mr. Walters has failed to

point to evidence connecting Defendants’ activities related to the Device to Massachusetts.

Further, all key events related to this case occurred elsewhere. Defendants manufactured the

Device in New York, [ECF No. 1-2 ¶ 17], and Mr. Walters (1) lives, (2) was implanted with the

Device, and (3) was allegedly injured and treated, in Texas, [ECF No. 1-1 ¶¶ 47, 49, 55]. Thus,

there is no perceptible connection between the work that Defendants do in Massachusetts and

Mr. Walters’ claims. See Ford Motor Co. v. Mont. Eighth Jud. Dist. Ct., 141 S. Ct. 1017, 1025

(2021) (noting that for specific personal jurisdiction to attach, “there must be ‘an affiliation

between the forum and the underlying controversy’” (quoting Bristol-Myers Squibb Co. v.

Super. Ct. of Cal., S.F. Cnty., 137 S. Ct. 1773, 1780 (2017))). Without such a connection,

Mr. Walters has not satisfied the relatedness prong of the specific personal jurisdiction analysis.

See Pettit, 2021 WL 4441261, at *7–8 (same finding with West Virginia plaintiff); Harness,

2021 WL 4441260, at *6 (same finding with Tennessee plaintiff); Kingston, 2021 WL 3022320,

at *7–8 (same finding with Kentucky plaintiff).

Because a plaintiff seeking to establish specific personal jurisdiction must satisfy all three

prongs, see Daynard, 290 F.3d at 60, and Mr. Walters has failed to satisfy the first, the Court

need not consider the other two.

D. Jurisdiction Via Service of Process

Mr. Walters argues that because Defendants were served in Massachusetts, they are

subject to personal jurisdiction here. [ECF No. 22 at 19–23]. He concedes that the

Massachusetts Supreme Judicial Court (“SJC”) has specifically declined to address “whether

presence in the forum State when served with process confers personal jurisdiction over

corporations,” Roch v. Mollica, 113 N.E.3d 820, 822 n.3 (Mass. 2019);5 see [ECF No. 22 at 21

(Mr. Walters’ concession)], but maintains that “the jurisprudence of the courts of the

Commonwealth and of the First Circuit have consistently held that such in-state service of

process confers personal jurisdiction over corporate entities,” [ECF No. 22 at 21]. The cases that

Mr. Walters cites, however, all pre-date Daimler, the Supreme Court’s seminal case concerning

general personal jurisdiction over corporate defendants. See [ECF No. 22 at 21–23 (citing cases

from 1916, 1936, 1937, 1948, 1952, 1953, 1966, 1980, 1985, and 2001)]. In Daimler, the

Supreme Court held that corporations are subject to general personal jurisdiction where they are

incorporated, where they have their principal places of business, and any other place where their

affiliations with the forum render the corporation “at home” there. 571 U.S. at 137–39. Were

the Court to accept Mr. Walters’ argument, Daimler would be rendered meaningless because

corporate defendants would be subject to personal jurisdiction wherever they conduct business

5 The footnote in which the SJC declined to address that question suggests strongly that the SJC

would find in-forum service of process insufficient to confer personal jurisdiction over a

corporate defendant were it faced with that question. See Roch, 113 N.E.3d at 822 n.3 (citing

cases suggesting that “tag jurisdiction” is unconstitutional as to corporate defendants).

and could be served, a proposition that the Supreme Court rejected. See id. at 138 (rejecting the

notion that a corporation is subject to general personal jurisdiction in every state where it

“engages in a substantial, continuous, and systematic course of business” because “[t]hat

formulation [would be] unacceptably grasping”). Accordingly, Mr. Walters’ argument fails.

E. Jurisdictional Discovery

Mr. Walters contends that he should be permitted to conduct jurisdictional discovery if

the Court finds that he has failed to meet his burden on the jurisdiction front. [ECF No. 22 at

23–26]. The First Circuit has “long held that ‘a diligent plaintiff who sues an out-of-state

corporation and who makes out a colorable case for the existence of in personam jurisdiction

may well be entitled to a modicum of jurisdictional discovery if the corporation interposes a

jurisdictional defense.’” Swiss Am. Bank, 274 F.3d at 625 (quoting Sunview Condo. Ass’n v.

Flexel Int’l, Ltd., 116 F.3d 962, 964 (1st Cir. 1997)). “However, that entitlement is not absolute.

. . . [E]ven when the plaintiff has been diligent and has made a colorable claim for personal

jurisdiction, the district court still has broad discretion to decide whether discovery is required.”

Id. at 625–26 (citations and internal quotation marks omitted). Further, “[i]n addition to making

a colorable claim, it is also incumbent upon the plaintiff to ‘present facts to the court which show

why jurisdiction would be found if discovery were permitted.’” Rain ex rel. Crandall v. Conn.

Gen. Corp., No. 17-cv-30115, 2019 WL 7604856, at *7 (D. Mass. Aug. 6, 2019) (quoting

Negron-Torres v. Verizon Commc’ns, Inc., 478 F.3d 19, 27 (1st Cir. 2007)).

Here, Mr. Walters has failed to make a “colorable case for the existence of” personal

jurisdiction, and the Court declines to exercise its discretion to grant jurisdictional discovery.

Swiss Am. Bank, 274 F.3d at 625 (citations and internal quotation marks omitted). Although

Mr. Walters’ arguments in favor of jurisdictional discovery are more compelling than those of

the plaintiffs in Kingston, Pettit, and Harness, the Court does not reach a different result here,

particularly given that discovery is unlikely to result in a finding that the Court has personal

jurisdiction over Defendants. See Kingston, 2021 WL 3022320, at *9 (denying jurisdictional

discovery because plaintiff’s “argument that certain operations occurred in Defendants’

Massachusetts location, and that these operations led to the ultimate—and allegedly flawed—

design of the [Device], which led to its eventual manufacture in New York, which led to its

distribution to and subsequent harm in Kentucky, is too tenuous to state a colorable claim”).

Accordingly, Mr. Walters’ request for jurisdictional discovery is DENIED.

IV. CONCLUSION

For the reasons set forth above, Mr. Walters’ motion for remand, [ECF No. 15], is

DENIED, and Defendants’ motion to dismiss for lack of personal jurisdiction, [ECF No. 8], is

GRANTED. Mr. Walters’ complaint, [ECF No. 1-1], is DISMISSED without prejudice.

SO ORDERED.

October 28, 2021 /s/ Allison D. Burroughs

ALLISON D. BURROUGHS

U.S. DISTRICT JUDGE